BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 32083761)

  • 1. Model for End-Stage Liver Disease-Lactate and Prediction of Inpatient Mortality in Patients With Chronic Liver Disease.
    Sarmast N; Ogola GO; Kouznetsova M; Leise MD; Bahirwani R; Maiwall R; Tapper E; Trotter J; Bajaj JS; Thacker LR; Tandon P; Wong F; Reddy KR; O'Leary JG; Masica A; Modrykamien AM; Kamath PS; Asrani SK
    Hepatology; 2020 Nov; 72(5):1747-1757. PubMed ID: 32083761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding C-reactive protein and procalcitonin to the model of end-stage liver disease score improves mortality prediction in patients with complications of cirrhosis.
    Chirapongsathorn S; Bunraksa W; Chaiprasert A; Punpanich D; Supasyndh O; Kamath PS
    J Gastroenterol Hepatol; 2018 Mar; 33(3):726-732. PubMed ID: 28840619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
    Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Kim WR; Mannalithara A; Heimbach JK; Kamath PS; Asrani SK; Biggins SW; Wood NL; Gentry SE; Kwong AJ
    Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MELD-Lactate Predicts Poor Outcome in Variceal Bleeding in Cirrhosis.
    Horvatits T; Mahmud N; Serper M; Seiz O; Reher D; Drolz A; Sarnast N; Gu W; Erasmus HP; Allo G; Ferstl P; Wittmann S; Piecha F; Groth S; Zeuzem S; Schramm C; Huber S; Rösch T; Lohse AW; Trebicka J; Ogola G; Asrani SK; Kluwe J
    Dig Dis Sci; 2023 Mar; 68(3):1042-1050. PubMed ID: 36376577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
    Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
    World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.
    Chen PC; Chen BH; Huang CH; Jeng WJ; Hsieh YC; Teng W; Chen YC; Ho YP; Sheen IS; Lin CY
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1256-1263. PubMed ID: 31498284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Mortality in the Critically Ill Cirrhotic Patient: Is the Model for End-Stage Liver Disease Enough?
    Annamalai A; Harada MY; Chen M; Tran T; Ko A; Ley EJ; Nuno M; Klein A; Nissen N; Noureddin M
    J Am Coll Surg; 2017 Mar; 224(3):276-282. PubMed ID: 27887981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the prognostic value of mortality Child Pugh Score and forecasting models of chronic liver disease in patients with decompensated cirrhosis of the Hospital Nacional Cayetano Heredia, Lima-Peru].
    Valenzuela Granados V; Salazar-Quiñones M; Cheng-Zárate L; Malpica-Castillo A; Huerta Mercado J; Ticse R
    Rev Gastroenterol Peru; 2015; 35(4):307-12. PubMed ID: 26802883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Predictive Role of Model for End-Stage Liver Disease-Lactate and Lactate Clearance for In-Hospital Mortality Among a National Cirrhosis Cohort.
    Mahmud N; Asrani SK; Kaplan DE; Ogola GO; Taddei TH; Kamath PS; Serper M
    Liver Transpl; 2021 Feb; 27(2):177-189. PubMed ID: 33025731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients With Persistently Low MELD-Na Scores Continue to Be at Risk of Liver-related Death.
    Mazumder NR; Atiemo K; Daud A; Kho A; Abecassis M; Levitsky J; Ladner DP
    Transplantation; 2020 Jul; 104(7):1413-1418. PubMed ID: 31644488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for End-Stage Liver Disease Sodium as a Predictor of Surgical Risk in Cirrhotic Patients With Ascites.
    Maassel NL; Fleming MM; Luo J; Zhang Y; Pei KY
    J Surg Res; 2020 Jun; 250():45-52. PubMed ID: 32018142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience.
    Bajaj JS; O'Leary JG; Reddy KR; Wong F; Olson JC; Subramanian RM; Brown G; Noble NA; Thacker LR; Kamath PS;
    Hepatology; 2012 Dec; 56(6):2328-35. PubMed ID: 22806618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcomes After Transcatheter and Surgical Aortic Valve Replacement in Patients With Cirrhosis: A Guide for the Hepatologist.
    Peeraphatdit TB; Nkomo VT; Naksuk N; Simonetto DA; Thakral N; Spears GM; Harmsen WS; Shah VH; Greason KL; Kamath PS
    Hepatology; 2020 Nov; 72(5):1735-1746. PubMed ID: 32080875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for end-stage liver disease and pneumonia: An improved scoring model for critically ill cirrhotic patients with pneumonia.
    Gao F; Cai MX; Lin MT; Zhang LZ; Ruan QZ; Gao F
    Turk J Gastroenterol; 2019 Jun; 30(6):532-540. PubMed ID: 31144659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Model for End-Stage Liver Disease Score With Mortality in Emergency General Surgery Patients.
    Havens JM; Columbus AB; Olufajo OA; Askari R; Salim A; Christopher KB
    JAMA Surg; 2016 Jul; 151(7):e160789. PubMed ID: 27192189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Child-Pugh, MELD, and ALBI scores for predicting the in-hospital mortality in cirrhotic patients with acute-on-chronic liver failure.
    Peng Y; Qi X; Tang S; Deng H; Li J; Ning Z; Dai J; Hou F; Zhao J; Wang R; Guo X
    Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):971-80. PubMed ID: 27070325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reticulocyte count and hemoglobin concentration predict survival in candidates for liver transplantation.
    Parker R; Armstrong MJ; Bruns T; Hodson J; Rowe IA; Corbett CD; Reuken PA; Gunson BK; Houlihan DD; Stephenson B; Malessa C; Lester W; Ferguson JW
    Transplantation; 2014 Feb; 97(4):463-9. PubMed ID: 24531823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
    Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
    Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Prediction Models for Post-Operative Mortality in Patients With Cirrhosis.
    Mahmud N; Fricker Z; Hubbard RA; Ioannou GN; Lewis JD; Taddei TH; Rothstein KD; Serper M; Goldberg DS; Kaplan DE
    Hepatology; 2021 Jan; 73(1):204-218. PubMed ID: 32939786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.